{
  "company": {
    "name": "Ochre Bio",
    "website": "https://ochre-bio.com/",
    "record": "https://startuphistory.org/c/ochre-bio.com"
  },
  "status": null,
  "history_since": "2020-03-18T14:17:22.000Z",
  "baseline": {
    "snapshot_id": "2c09ae39ec002a7211a45cb47340f2ac6c30296cd28e21bd9c9f85dd691486c2",
    "observed_at": "2020-03-18T14:17:22.000Z",
    "headline": "genomic medicines",
    "description": "Ochre Bio develops genomic medicines to rejuvenate fatty donor livers before transplant, so that everyone who needs a new liver gets one.",
    "evidence": "https://web.archive.org/web/20200318141722/https://www.ochre-bio.com/",
    "evidence_kind": "internet_archive",
    "facts": null,
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 1,
  "last_checked": "2026-11-06T17:51:04.010Z",
  "live_status": null,
  "messaging": [
    {
      "quote_observed_at": "2022-01-03T21:38:34.000Z",
      "variants": [
        {
          "headline": "genomic medicines",
          "subhead": "Ochre Bio develops genomic medicines to rejuvenate fatty donor livers before transplant, so that everyone who needs a new liver gets one.",
          "observed_at": "2020-03-18T14:17:22.000Z",
          "evidence": "https://web.archive.org/web/20200318141722/https://www.ochre-bio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "genomic medicines",
          "subhead": "Ochre Bio develops genomic medicines to rejuvenate fatty donor livers before transplant, so that everyone who needs a new liver gets one.",
          "observed_at": "2020-11-01T00:17:06.000Z",
          "evidence": "https://web.archive.org/web/20201101001706/https://www.ochre-bio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Phenomics-led RNA medicines",
          "subhead": "Ochre Bio develops genomic medicines to rejuvenate fatty donor livers before transplant, so that everyone who needs a new liver gets one.",
          "observed_at": "2021-07-07T14:21:39.000Z",
          "evidence": "https://web.archive.org/web/20210707142139/https://www.ochre-bio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Phenomics-led RNA medicines",
          "subhead": "Ochre Bio develops genomic medicines to rejuvenate fatty donor livers before transplant, so that everyone who needs a new liver gets one.",
          "observed_at": "2022-01-03T21:38:34.000Z",
          "evidence": "https://web.archive.org/web/20220103213834/https://www.ochre-bio.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "Phenomics-led RNA medicines",
      "subhead": "Ochre Bio develops genomic medicines to rejuvenate fatty donor livers before transplant, so that everyone who needs a new liver gets one.",
      "from": "2020-03-18T14:17:22.000Z",
      "to": "2022-01-03T21:38:34.000Z",
      "captures": 4,
      "evidence": "https://web.archive.org/web/20220103213834/https://www.ochre-bio.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "between": {
          "from": "2020-03-18T14:17:22.000Z",
          "to": "2022-01-03T21:38:34.000Z"
        }
      },
      "current": false
    },
    {
      "quote_observed_at": "2023-09-26T21:00:41.000Z",
      "variants": [
        {
          "headline": "Oxford biotech raises funds to make RNA treatments for liver disease",
          "subhead": "Ochre Bio is developing therapies for the biggest liver health challenges.",
          "observed_at": "2023-01-20T14:41:54.000Z",
          "evidence": "https://web.archive.org/web/20230120144154/https://www.ochre-bio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Oxford biotech raises funds to make RNA treatments for liver disease",
          "subhead": "Ochre Bio is developing therapies for the biggest liver health challenges.",
          "observed_at": "2023-09-26T21:00:41.000Z",
          "evidence": "https://web.archive.org/web/20230926210041/https://www.ochre-bio.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "Oxford biotech raises funds to make RNA treatments for liver disease",
      "subhead": "Ochre Bio is developing therapies for the biggest liver health challenges.",
      "from": "2023-01-20T14:41:54.000Z",
      "to": "2023-09-26T21:00:41.000Z",
      "captures": 2,
      "evidence": "https://web.archive.org/web/20230926210041/https://www.ochre-bio.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "between": {
          "from": "2023-01-20T14:41:54.000Z",
          "to": "2023-09-26T21:00:41.000Z"
        }
      },
      "current": false
    },
    {
      "quote_observed_at": "2025-01-09T11:01:31.000Z",
      "variants": [
        {
          "headline": "GSK signs AI pact with Ochre to pinpoint source of liver diseases",
          "subhead": "Ochre Bio is developing therapies for the biggest liver health challenges.",
          "observed_at": "2024-07-13T23:07:36.000Z",
          "evidence": "https://web.archive.org/web/20240713230736/https://www.ochre-bio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "GSK signs AI pact with Ochre to pinpoint source of liver diseases",
          "subhead": "Ochre Bio is developing therapies for the biggest liver health challenges.",
          "observed_at": "2025-01-09T11:01:31.000Z",
          "evidence": "https://web.archive.org/web/20250109110131/https://www.ochre-bio.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "GSK signs AI pact with Ochre to pinpoint source of liver diseases",
      "subhead": "Ochre Bio is developing therapies for the biggest liver health challenges.",
      "from": "2024-07-13T23:07:36.000Z",
      "to": "2025-01-09T11:01:31.000Z",
      "captures": 2,
      "evidence": "https://web.archive.org/web/20250109110131/https://www.ochre-bio.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "between": {
          "from": "2024-07-13T23:07:36.000Z",
          "to": "2025-01-09T11:01:31.000Z"
        }
      },
      "current": false
    },
    {
      "quote_observed_at": "2026-11-06T17:51:04.010Z",
      "variants": [
        {
          "headline": "Human data. Human models. Human translation.",
          "subhead": "Ochre Bio is developing therapies for the biggest liver health challenges.",
          "observed_at": "2026-01-07T21:57:50.000Z",
          "evidence": "https://web.archive.org/web/20260107215750/https://www.ochre-bio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Human data. Human models. Human translation.",
          "subhead": "Ochre Bio is developing therapies for the biggest liver health challenges.",
          "observed_at": "2026-07-31T17:01:22.000Z",
          "evidence": "https://web.archive.org/web/20260731170122/https://www.ochre-bio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Human data. Human models. Human translation.",
          "subhead": "Ochre Bio is developing therapies for the biggest liver health challenges.",
          "observed_at": "2026-11-06T17:51:04.010Z",
          "evidence": "https://www.ochre-bio.com/",
          "evidence_kind": "live_capture"
        }
      ],
      "headline": "Human data. Human models. Human translation.",
      "subhead": "Ochre Bio is developing therapies for the biggest liver health challenges.",
      "from": "2026-01-07T21:57:50.000Z",
      "to": "2026-11-06T17:51:04.010Z",
      "captures": 3,
      "evidence": "https://www.ochre-bio.com/",
      "evidence_kind": "live_capture",
      "seen": {
        "between": {
          "from": "2026-01-07T21:57:50.000Z",
          "to": "2026-11-06T17:51:04.010Z"
        }
      },
      "current": true
    }
  ],
  "changes": [
    {
      "n": 1,
      "id": "classifier-6fda9018f08044fccc35e83204a1c302a1f177d3599c423b1b7731af1871a152:430a45a151c9e928ca0a67c748d3c977205e19a4e240a87bd92e8a41b407312a:repositioning",
      "before_evidence": "https://web.archive.org/web/20201101001706/https://www.ochre-bio.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "repositioning",
      "label": "Messaging",
      "summary": "Changed its homepage headline from “genomic medicines” to “Phenomics-led RNA medicines”.",
      "between": {
        "from": "2020-11-01T00:17:06.000Z",
        "to": "2021-07-07T14:21:39.000Z"
      },
      "evidence": "https://web.archive.org/web/20210707142139/https://www.ochre-bio.com/",
      "evidence_kind": "internet_archive",
      "basis": "classifier",
      "topic": "https://startuphistory.org/t/repositioned"
    },
    {
      "n": 2,
      "id": "page-bdbeadbe8a3a8b62dea6ae0e707c9393d591514aa9ed48c5c773a5014128749f:670dfa1d11b670050b3ed2f20e3c9a3ac8c9e1463ffb64181892b3e584f8ea1e:headline:5736fbf6210976d4",
      "before_evidence": "https://web.archive.org/web/20220103213834/https://www.ochre-bio.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "headline",
      "label": "Headline",
      "summary": "Changed its homepage headline from “Phenomics-led RNA medicines” to “Oxford biotech raises funds to make RNA treatments for liver disease”.",
      "between": {
        "from": "2022-01-03T21:38:34.000Z",
        "to": "2023-01-20T14:41:54.000Z"
      },
      "evidence": "https://web.archive.org/web/20230120144154/https://www.ochre-bio.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": null
    },
    {
      "n": 3,
      "id": "page-bdbeadbe8a3a8b62dea6ae0e707c9393d591514aa9ed48c5c773a5014128749f:670dfa1d11b670050b3ed2f20e3c9a3ac8c9e1463ffb64181892b3e584f8ea1e:hiring:20dd4c09cc4ab0aa",
      "before_evidence": "https://web.archive.org/web/20220103213834/https://www.ochre-bio.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "hiring",
      "label": "Hiring",
      "summary": "Added a careers page.",
      "between": {
        "from": "2022-01-03T21:38:34.000Z",
        "to": "2023-01-20T14:41:54.000Z"
      },
      "evidence": "https://web.archive.org/web/20230120144154/https://www.ochre-bio.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": "https://startuphistory.org/t/added-careers-page"
    },
    {
      "n": 4,
      "id": "page-920d224d995a84f496eabade00c1020371aaa4175315be5c41d327575114b51c:9dd127d484310df88b3d4a0ba9fa7c81327cd32acdab4b8bf3120fcfd9465ecb:headline:411faa7f1c6d0fcb",
      "before_evidence": "https://web.archive.org/web/20230926210041/https://www.ochre-bio.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "headline",
      "label": "Headline",
      "summary": "Changed its homepage headline from “Oxford biotech raises funds to make RNA treatments for liver disease” to “GSK signs AI pact with Ochre to pinpoint source of liver diseases”.",
      "between": {
        "from": "2023-09-26T21:00:41.000Z",
        "to": "2024-07-13T23:07:36.000Z"
      },
      "evidence": "https://web.archive.org/web/20240713230736/https://www.ochre-bio.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": null
    },
    {
      "n": 5,
      "id": "page-9dd127d484310df88b3d4a0ba9fa7c81327cd32acdab4b8bf3120fcfd9465ecb:ac56dca9f89858b6675490cce72ffc3676cea3363e56c7074964e8ed7665ce75:investors:499d8db39497839b",
      "before_evidence": "https://web.archive.org/web/20240713230736/https://www.ochre-bio.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "investors",
      "label": "Investors",
      "summary": "Now shows investor logos: GSK-, khosla ventures, backedvclogo, Alexandria_Real_Estate_Equities_logo, ApolloVC_LogoUpdate, lifelinkventures and hermes epitek.",
      "between": {
        "from": "2024-07-13T23:07:36.000Z",
        "to": "2025-01-09T11:01:31.000Z"
      },
      "evidence": "https://web.archive.org/web/20250109110131/https://www.ochre-bio.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": "https://startuphistory.org/t/added-investor-logos"
    },
    {
      "n": 6,
      "id": "page-ac56dca9f89858b6675490cce72ffc3676cea3363e56c7074964e8ed7665ce75:f8bf7f742ba2d4686901095b6c6aed23db18eb390e9e9590ce54044c5193f0ed:headline:7464d44d86866324",
      "before_evidence": "https://web.archive.org/web/20250109110131/https://www.ochre-bio.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "headline",
      "label": "Headline",
      "summary": "Changed its homepage headline from “GSK signs AI pact with Ochre to pinpoint source of liver diseases” to “Human data. Human models. Human translation.”.",
      "between": {
        "from": "2025-01-09T11:01:31.000Z",
        "to": "2026-01-07T21:57:50.000Z"
      },
      "evidence": "https://web.archive.org/web/20260107215750/https://www.ochre-bio.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": null
    }
  ],
  "update": {
    "headline": "Ochre Bio updates homepage messaging and shows investor logos",
    "summary": "Ochre Bio has revised its homepage headlines multiple times, added a careers page, and now displays several investor logos.",
    "points": [
      {
        "text": "Between November 2020 and July 2021, a classifier read Ochre Bio’s homepage change from “genomic medicines” to “Phenomics-led RNA medicines” as a repositioning.",
        "kind": "interpretation",
        "changes": [
          1
        ]
      },
      {
        "text": "Between January 2022 and January 2023, Ochre Bio changed its homepage headline to “Oxford biotech raises funds to make RNA treatments for liver disease”.",
        "kind": "fact",
        "changes": [
          2
        ]
      },
      {
        "text": "Between January 2022 and January 2023, Ochre Bio added a careers page.",
        "kind": "fact",
        "changes": [
          3
        ]
      },
      {
        "text": "Between July 2024 and January 2025, Ochre Bio began showing investor logos: GSK-, khosla ventures, backedvclogo, Alexandria_Real_Estate_Equities_logo, ApolloVC_LogoUpdate, lifelinkventures and hermes epitek.",
        "kind": "fact",
        "changes": [
          5
        ]
      }
    ],
    "written_at": "2026-11-07T15:03:33.260Z",
    "basis": "ai_analysis",
    "model": "gpt-5.1-2025-11-13"
  },
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “Ochre Bio” company record, https://startuphistory.org/c/ochre-bio.com"
}